Document 2152
 DOCN  M94A2152
 TI    HIV seroprevalence trends in the United States 1988-1992.
 DT    9412
 AU    Petersen LR; Gwinn M; Janssen R; Centers for Disease Control and
       Prevention, Atlanta, GA.
 SO    Int Conf AIDS. 1994 Aug 7-12;10(1):37 (abstract no. 123C). Unique
       Identifier : AIDSLINE ICA10/94370423
 AB    OBJECTIVE: Determine trends in HIV-1 seroprevalence among sentinel
       populations in the United States. METHODS: We reviewed seroprevalence
       data from annual anonymous [unlinked] surveys among childbearing women
       (N = 9,000,000) and clients of sexually transmitted disease (STD)
       clinics (N = 349,000) and drug treatment (DT) clinics (N = 43,500) in 40
       cities and from national routine screening of military applicants (N =
       3,726,000), disadvantaged youth entering a national job training program
       (Job Corps; N = 270,000), and first-time blood donors (N = 7,205,000).
       We compared rates for 1989-90 surveys with rates in 1991-92. RESULTS:
       During 1991-92, prevalence exceeded 15% among men who had sex with men
       (MSM) in nearly every STD clinic (median 26%); the absolute HIV
       prevalence decreased by a median of 5.7% from 1989-90. In contrast,
       prevalence in 1991-92 among injection drug users (IDU) entering DT
       ranged from 15-40% in eastern cities and was < 7% elsewhere, without a
       clear trend in prevalence. Prevalence among men applying for military
       service, entering the Job Corps, and donating blood decreased markedly,
       while prevalence among women remained stable or increased. In these
       populations, seroprevalence in women now is nearly equal to or exceeds
       that of men. Prevalence among childbearing women increased from 0.16% in
       1989-90 to 0.17% in 1991-92, with decreasing trends in the Northeast and
       increasing trends in the South, particularly among blacks. CONCLUSION:
       Prevalence among men is generally decreasing, particularly among MSM
       attending STD clinics, while prevalence among women is stable or
       increasing. Prevalence among IDUs entering DT did not change. These
       results indicate a substantial shift in the HIV epidemic, with greater
       relative importance of HIV in women, IDUs and African Americans.
 DE    Female  Homosexuality  Human  HIV Seroprevalence/*TRENDS  Male
       *Population Surveillance  Pregnancy  Pregnancy Complications, Infectious
       Risk Factors  Seroepidemiologic Methods  Sexually Transmitted
       Diseases/COMPLICATIONS  Substance Abuse, Intravenous/COMPLICATIONS
       United States/EPIDEMIOLOGY  MEETING ABSTRACT

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).